Development of a Standardized Data Collection Tool for Evaluation and Management of Coronavirus Disease 2019.
coronavirus-19
data collection tool
hospitalized
Journal
Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
received:
02
07
2020
accepted:
24
07
2020
entrez:
22
9
2020
pubmed:
23
9
2020
medline:
23
9
2020
Statut:
epublish
Résumé
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 ) is responsible for coronavirus disease 2019 (COVID-19), a disease that had not been previously described and for which clinicians need to rapidly adapt their daily practice. The novelty of SARS-CoV-2 produced significant gaps in harmonization of definitions, data collection, and outcome reporting to identify patients who would benefit from potential interventions. We describe a multicenter collaboration to develop a comprehensive data collection tool for the evaluation and management of COVID-19 in hospitalized patients. The proposed tool was developed by a multidisciplinary working group of infectious disease physicians, intensivists, and infectious diseases/antimicrobial stewardship pharmacists. The working group regularly reviewed literature to select important patient characteristics, diagnostics, and outcomes for inclusion. The data collection tool consisted of spreadsheets developed to collect data from the electronic medical record and track the clinical course after treatments. Data collection focused on demographics and exposure epidemiology, prior medical history and medications, signs and symptoms, diagnostic test results, interventions, clinical outcomes, and complications. During the pilot validation phase, there was <10% missing data for most domains and components. Team members noted improved efficiency and decision making by using the tool during interdisciplinary rounds. We present the development of a COVID-19 data collection tool and propose its use to effectively assemble harmonized data of hospitalized individuals with COVID-19. This tool can be used by clinicians, researchers, and quality improvement healthcare teams. It has the potential to facilitate interdisciplinary rounds, provide comparisons across different hospitalized populations, and adapt to emerging challenges posed by the pandemic.
Sections du résumé
BACKGROUND
BACKGROUND
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 ) is responsible for coronavirus disease 2019 (COVID-19), a disease that had not been previously described and for which clinicians need to rapidly adapt their daily practice. The novelty of SARS-CoV-2 produced significant gaps in harmonization of definitions, data collection, and outcome reporting to identify patients who would benefit from potential interventions.
METHODS
METHODS
We describe a multicenter collaboration to develop a comprehensive data collection tool for the evaluation and management of COVID-19 in hospitalized patients. The proposed tool was developed by a multidisciplinary working group of infectious disease physicians, intensivists, and infectious diseases/antimicrobial stewardship pharmacists. The working group regularly reviewed literature to select important patient characteristics, diagnostics, and outcomes for inclusion. The data collection tool consisted of spreadsheets developed to collect data from the electronic medical record and track the clinical course after treatments.
RESULTS
RESULTS
Data collection focused on demographics and exposure epidemiology, prior medical history and medications, signs and symptoms, diagnostic test results, interventions, clinical outcomes, and complications. During the pilot validation phase, there was <10% missing data for most domains and components. Team members noted improved efficiency and decision making by using the tool during interdisciplinary rounds.
CONCLUSIONS
CONCLUSIONS
We present the development of a COVID-19 data collection tool and propose its use to effectively assemble harmonized data of hospitalized individuals with COVID-19. This tool can be used by clinicians, researchers, and quality improvement healthcare teams. It has the potential to facilitate interdisciplinary rounds, provide comparisons across different hospitalized populations, and adapt to emerging challenges posed by the pandemic.
Identifiants
pubmed: 32959015
doi: 10.1093/ofid/ofaa320
pii: ofaa320
pmc: PMC7454902
doi:
Types de publication
Journal Article
Langues
eng
Pagination
ofaa320Subventions
Organisme : NIAID NIH HHS
ID : P30 AI073961
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000460
Pays : United States
Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Références
N Engl J Med. 2020 May 7;382(19):1787-1799
pubmed: 32187464
Lancet. 2020 May 16;395(10236):1569-1578
pubmed: 32423584
Hematology. 2012 Apr;17 Suppl 1:S144-6
pubmed: 22507804
Intensive Care Med. 2020 May;46(5):846-848
pubmed: 32125452
MMWR Morb Mortal Wkly Rep. 2020 Apr 03;69(13):382-386
pubmed: 32240123
Lancet Infect Dis. 2020 May;20(5):533-534
pubmed: 32087114
JAMA Cardiol. 2020 Jul 1;5(7):802-810
pubmed: 32211816
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Clin Chim Acta. 2020 Jun;505:190-191
pubmed: 32145275
Lab Invest. 2020 Jun;100(6):794-800
pubmed: 32341519
Tob Induc Dis. 2020 Mar 20;18:20
pubmed: 32206052
Prof Case Manag. 2015 Nov-Dec;20(6):299-307; quiz 308-9
pubmed: 26437135
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Clin Infect Dis. 2020 Jul 28;71(15):896-897
pubmed: 32271368
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
J Infect. 2020 Aug;81(2):e16-e25
pubmed: 32335169
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):458-464
pubmed: 32298251
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
JAMA Intern Med. 2020 Aug 1;180(8):1081-1089
pubmed: 32396163
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Clin Infect Dis. 2020 Apr 27;:
pubmed: 32338708
Clin Infect Dis. 2020 Jul 28;71(15):833-840
pubmed: 32296824
Obesity (Silver Spring). 2020 Jul;28(7):1200-1204
pubmed: 32352637
Lancet Oncol. 2020 Mar;21(3):335-337
pubmed: 32066541
JAMA. 2020 May 12;323(18):1775-1776
pubmed: 32203977
JAMA. 2020 May 12;323(18):1824-1836
pubmed: 32282022
JAMA Intern Med. 2020 Jul 1;180(7):934-943
pubmed: 32167524
Intensive Care Med. 1996 Jul;22(7):707-10
pubmed: 8844239
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
N Engl J Med. 2020 Nov 5;383(19):1813-1826
pubmed: 32445440
J Heart Lung Transplant. 2020 May;39(5):405-407
pubmed: 32362390
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143